The Exposome in Cancer Disparities
Influence of Environmental and Infectious Factors in LMICs
- 1st Edition - May 1, 2026
- Latest edition
- Editor: Zodwa Dlamini
- Language: English
The Exposome in Cancer Disparities: Influence of Environmental and Infectious Factors in LMICs examines how environmental and infectious factors drive cancer inequities in low- a… Read more
The Exposome in Cancer Disparities: Influence of Environmental and Infectious Factors in LMICs examines how environmental and infectious factors drive cancer inequities in low- and middle-income countries (LMICs). The book introduces the exposome as a comprehensive framework to understand complex risk factors, such as environmental toxins, climate change, and infectious agents like HPV and HIV. The book combines scientific insights, real-world case studies, and practical strategies from international experts, highlighting region-specific contributors to cancer disparities. Structured into thematic sections, it offers a holistic view of the challenges faced by LMICs and provides actionable, evidence-based solutions tailored to resource-limited settings.
The work emphasizes the importance of multidisciplinary approaches and international collaboration to develop effective prevention and policy strategies. It will benefit researchers, policymakers, and healthcare professionals by deepening understanding of cancer risk factors, fostering global cooperation and guiding targeted interventions to reduce health inequities and improve outcomes worldwide.
The work emphasizes the importance of multidisciplinary approaches and international collaboration to develop effective prevention and policy strategies. It will benefit researchers, policymakers, and healthcare professionals by deepening understanding of cancer risk factors, fostering global cooperation and guiding targeted interventions to reduce health inequities and improve outcomes worldwide.
- Introduces the exposome as a transformative framework for understanding the complex interplay of environmental and infectious factors in cancer disparities
- Integrates scientific insights, case studies, and practical strategies from international experts to provide a holistic and actionable perspective
- Emphasizes the importance of multidisciplinary approaches and international collaboration to develop effective prevention and policy interventions in resource-limited settings
Cancer researchers, epidemiologists, public health professionals, and healthcare practitioners focused on oncology and environmental health
Part 1: Foundations of Exposomics and Cancer Disparities
1. Introduction: The Exposome Framework and Its Relevance to Cancer Disparities
2. Environmental Exposures and Cancer Risk: An Exposomics Perspective in LMICs
3. Infectious Agents, HIV, and the Carcinogenic Risks in LMICs
4. Socioeconomic Inequities and the Exposome: A Double Burden in LMICs
Part 2: Mechanisms and Intersections of the Exposome
5. NTDs, Co-Infections, and the Exposome: The Overlapping Burden in LMICs
6. Climate Change, the Exposome, and Cancer Disparities in LMICs
7. Culture, Society, and the Exposome: Understanding Cancer Risk in LMICs
8. Gene-Environment Interactions: The Exposome and Cancer Susceptibility
9. The Microbiome and the Exposome: Implications for Cancer Risk
Part 3: Exposome-Informed Strategies for Cancer Prevention and Equity
10. Cancer Prevention in LMICs: Targeting Environmental and Infectious Exposures
11. Strengthening Healthcare Systems Through Exposomics
12. Policy Reform and Environmental Justice: Bridging Gaps in Cancer Prevention
Part 4: Innovations and Global Collaboration in Exposomics
13. Emerging Technologies in Exposomics: Advancing Cancer Diagnosis and Treatment
14. AI, Big Data, and the Exposome: Transforming Cancer Risk Assessment
15. Global Collaboration in Exposomics: A Multi-Stakeholder Approach to Reducing Cancer Disparities
16. The Future of Exposomics: Pathways to Address Cancer Disparities in LMICs
1. Introduction: The Exposome Framework and Its Relevance to Cancer Disparities
2. Environmental Exposures and Cancer Risk: An Exposomics Perspective in LMICs
3. Infectious Agents, HIV, and the Carcinogenic Risks in LMICs
4. Socioeconomic Inequities and the Exposome: A Double Burden in LMICs
Part 2: Mechanisms and Intersections of the Exposome
5. NTDs, Co-Infections, and the Exposome: The Overlapping Burden in LMICs
6. Climate Change, the Exposome, and Cancer Disparities in LMICs
7. Culture, Society, and the Exposome: Understanding Cancer Risk in LMICs
8. Gene-Environment Interactions: The Exposome and Cancer Susceptibility
9. The Microbiome and the Exposome: Implications for Cancer Risk
Part 3: Exposome-Informed Strategies for Cancer Prevention and Equity
10. Cancer Prevention in LMICs: Targeting Environmental and Infectious Exposures
11. Strengthening Healthcare Systems Through Exposomics
12. Policy Reform and Environmental Justice: Bridging Gaps in Cancer Prevention
Part 4: Innovations and Global Collaboration in Exposomics
13. Emerging Technologies in Exposomics: Advancing Cancer Diagnosis and Treatment
14. AI, Big Data, and the Exposome: Transforming Cancer Risk Assessment
15. Global Collaboration in Exposomics: A Multi-Stakeholder Approach to Reducing Cancer Disparities
16. The Future of Exposomics: Pathways to Address Cancer Disparities in LMICs
- Edition: 1
- Latest edition
- Published: May 1, 2026
- Language: English
ZD
Zodwa Dlamini
Zodwa Dlamini is a Professor of Molecular Oncology and the founding Director and the Executive Head of the Pan African Cancer Research Institute (PACRI) in South Africa. She is the Director of South African Medical Research Council (SAMRC) Precision Oncology Research Unit (PORU). She is the DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP). She is a member of the American Association for Cancer Research (AACR) Advisory Group on Sub-Saharan Africa. She is a member of the AACR Pathology Resources in Africa Advisory Group. Professor Dlamini is a member of the African Organisation for Research and Training in Cancer (AORTIC) Research Committee Scientific Advisory Board. She is an elected member of the Academy of Science of South Africa. Professor Dlamini is an overseas Fellow of the Royal Society of Medicine (London). She is the Associate Editor for Frontiers in Oncology: Cancer Genetics Section
Affiliations and expertise
University of Pretoria, South Africa